South Carolina Patent of the Month – September 2024
Poly-Med, Inc. has introduced a groundbreaking development in photopolymerizable compounds for 3D printing applications, with a focus on producing biodegradable medical devices. This innovative material technology features a unique central core with multiple light-reactive arms that can be precisely crosslinked by UV or visible light, forming durable, biodegradable structures. Key to Poly-Med’s invention is the flexibility of its compound design, allowing the use of different monomers and functional groups to tailor the mechanical and degradation properties of the resulting material.
This customization enables the production of medical devices that can gradually degrade within the body, such as tissue repair meshes and implant coatings, providing structural support only as long as necessary before safely dissolving. This approach not only improves patient outcomes but also minimizes the need for additional procedures to remove implants once healing is complete.
Poly-Med’s compounds enable stereolithography (SLA) printing, where the material is cured layer-by-layer with light to achieve precise shapes and properties, ideal for applications requiring complex or patient-specific geometries. The polymer’s photocurable design ensures compatibility with SLA and other photopolymerization-based printing methods, opening up possibilities for customized, bioabsorbable devices that maintain their form and function until they are no longer needed.
This technology stands to transform how medical devices are designed, offering tailored degradation rates, enhanced biocompatibility, and the flexibility needed for diverse applications in tissue engineering and regenerative medicine. Poly-Med’s photopolymerizable compounds are pushing the boundaries of biodegradable 3D-printed medical devices, aligning advanced materials science with personalized, patient-centered healthcare solutions.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
